Karina L Vivar

Dr. Karina L Vivar serves as a Clinical Assistant Professor in the Department of Dermatology at Northwestern University's Feinberg School of Medicine, practicing at Ann & Robert H. Lurie Children's Hospital of Chicago with additional affiliations at Northwestern Medicine Lake Forest Hospital and Northwestern Memorial Hospital.

Her academic credentials include an MD from New York University School of Medicine (2011), Pediatrics residency at University of California-San Francisco Medical Center (2014), Dermatology residency at University of South Florida (2017), and Pediatric Dermatology fellowship at Northwestern University (2018). She maintains board certification in Pediatrics, Dermatology, and Pediatric Dermatology through the American Board of Pediatrics and American Board of Dermatology.

Dr. Vivar's clinical and research expertise centers on pediatric dermatology with specialized focus on oncologic dermatology and dermatologic care for stem cell/solid organ transplant recipients. Her practice encompasses inflammatory skin diseases, vascular anomalies, melanocytic lesions, and advanced dermatologic surgical techniques including laser therapy. Current research examines psychosocial impacts of chronic skin conditions and cutaneous toxicities from oncology treatments.

She actively contributes to the Pediatric Dermatology Research Alliance (PeDRA) as member of both the Skin of Color & Pigmentary Disorders Focused Study Group and Inpatient Special Interest Group. Professional affiliations include Fellow of the American Academy of Dermatology (2014-present), Society for Pediatric Dermatology (2013-present), and Fellow of the American Academy of Pediatrics (2011-present).

Her publication record demonstrates significant contributions to understanding mucocutaneous toxicities from targeted cancer therapies, mental health impacts of chronic pediatric skin disorders, and rare genetic dermatological conditions. Recent work appears in high-impact journals including JAMA Dermatology and Journal of Investigative Dermatology.

Dr. Vivar engages in industry consultation for Day One Biopharmaceuticals, Inc. and Gusto Peds 360 Plus Corp as disclosed for 2024, maintaining active involvement with Northwestern University Clinical and Translational Sciences Institute (NUCATS) to advance clinical research methodologies.